Company intelligence / Profile preview

Bridgepoint

San Diego?, California?bridgepointgroup.com ↗

Ownership: Private
Development stage: Other

Overview

BridgePoint Bio is an active biotech consulting firm specializing in scientific education and advisory services for the life sciences industry. Founded by molecular biologist Kevin Curran PhD, the company provides seminars and custom courses on advanced therapeutic modalities such as gene editing, RNA therapies, CAR-T cell therapies, AAV gene therapies, ADCs, and bispecific antibodies. Their clients include major pharmaceutical companies as well as academic institutions. They do not have their own clinical pipeline but support education around cutting-edge clinical developments.

Modalities: RNA therapyGene therapy (AAV gene therapy)CAR-T cell therapyCell therapyAntibody-drug conjugateBispecific monoclonal antibody
Industry: Consulting

Partnerships

Caring Cross (educational series)various pharma/biotech clients

Beyond the preview

Go deeper on Bridgepoint.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bridgepoint.

Explore the full profile